• Adrian Simpson, United States says, "If you are looking for a fair deal on medical supplies, IDM is something I would seriously recommend. Am hooked for life."
  • Craig, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "IDM makes online shopping a pleasure. Shopping is so simple that you just breeze through it."
  • Harry Mason, United States says, "I have to admit am a bit of a lazy bloke when it comes to ordering online .And IDM pampers me to the hit as it's so simple to order."
  • John Hanks, United States says, "I was a sceptic until my first order. After, I received my first package, I turned believer. Now, it’s been 3 years since I have been ordering from IDM."
  • Natalie Wallace, United States says, "I was apprehensive about how my doubts would be addressed but what the heck,I went ahead and placed my order. Customer service was patient and helped me out."
  • Mark Penning, United States says, "Happy I got my package just in time for my vacation. Needless to say, it made my holiday a wonderfully satisfying experience."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    You can find the latest happening of our pharmacy
    Follow us on Twitter

      South Africa's Aspen, India's Lupin in TB drugs

      Posted AtReuters

      Africa's biggest generics drugs maker Aspen has concluded a joint venture with India's Lupin to collaborate on tuberculosis (TB) related products in South Africa, it said on Monday.

      HIV/AIDS, which affects more people in South Africa than any other country, has raised TB infection rates, placing immense pressure on stretched healthcare resources.

      Aspen said in a statement that its agreement with Lupin involved cooperation in technology, manufacture and marketing.

      Aspen said the market for TB medication in South Africa was worth around $15 million per annum and it expected to pay up to $2 million to Lupin depending on certain conditions, although it did not give a time scale for such payments.

      The parties will also share profits from the joint venture.

      Mumbai-based Lupin makes and markets generic intermediates, active pharmaceutical ingredients and finished drug dosages. Eleven of Lupin's plants have been approved by U.S. regulators and two of its facilities have been approved by UK authorities.

      Last week Aspen agreed terms for two joint ventures with another Indian group, Matrix Laboratories, to cater for South Africa's large demand for AIDS medication.

      September 26, 2005


      Share this Article!

    Back to top^